MDMA-Assisted Therapy for Veterans With Moderate to Severe Post Traumatic Stress Disorder
Phase 2
40
about 1.1 years
18+
2 sites in CA
What this study is about
Researchers are testing whether MDMA-assisted therapy, combined with psychotherapy, is more effective than low dose d-amphetamine-assisted therapy at reducing PTSD symptoms in veterans. The trial will last 395 days and involve approximately 40 participants aged 18 or older who have moderate to severe PTSD.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Participate in Therapy
- 2.Take 3,4-methylenedioxymethamphetamine
- 3.Take d-amphetamine
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
dexamfetamine
Primary: Compare changes in PTSD symptom severity in the MDMA vs active control group.
Psychiatry / Mental Health